Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15189-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- GFPT2 antibody
- Antibody type
- Polyclonal
- Description
- GFPT2 antibody (Cat. #15189-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IP, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Deamidation enables pathogenic SMAD6 variants to activate the BMP signaling pathway.
Dihydroartemisinin promotes tau O-GlcNAcylation and improves cognitive function in hTau transgenic mice.
Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P.
A roadmap for the characterization of energy metabolism in human cardiomyocytes derived from induced pluripotent stem cells.
Li L, Lu L, Xiao Z, Lv J, Huang H, Wu B, Zhao T, Li C, Wang W, Wang H
Science China. Life sciences 2024 Sep;67(9):1915-1927
Science China. Life sciences 2024 Sep;67(9):1915-1927
Dihydroartemisinin promotes tau O-GlcNAcylation and improves cognitive function in hTau transgenic mice.
Xia L, Li J, Pang Y, Xu M, Du Y, Chen M, Xu B, Qiu Y, Dong Z
Progress in neuro-psychopharmacology & biological psychiatry 2024 Dec 20;135:111105
Progress in neuro-psychopharmacology & biological psychiatry 2024 Dec 20;135:111105
Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P.
Ai YL, Wang WJ, Liu FJ, Fang W, Chen HZ, Wu LZ, Hong X, Zhu Y, Zhang CX, Liu LY, Hong WB, Zhou B, Chen QT, Wu Q
Cell research 2023 Dec;33(12):904-922
Cell research 2023 Dec;33(12):904-922
A roadmap for the characterization of energy metabolism in human cardiomyocytes derived from induced pluripotent stem cells.
Emanuelli G, Zoccarato A, Reumiller CM, Papadopoulos A, Chong M, Rebs S, Betteridge K, Beretta M, Streckfuss-Bömeke K, Shah AM
Journal of molecular and cellular cardiology 2022 Mar;164:136-147
Journal of molecular and cellular cardiology 2022 Mar;164:136-147
No comments: Submit comment
No validations: Submit validation data